The Antivenin,crotalidae,polyvalent, cataloged under National Stock Number 6505-01-696-3047, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Rare Disease Therapeutics, Inc. Dba Rare Disease Therapeutics Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-696-3047 |
| Primary Part Number | NDC66621-0790-02 |
| Item Name | Antivenin,crotalidae,polyvalent |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Rare Disease Therapeutics, Inc. Dba Rare Disease Therapeutics Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC66621-0790-02 PRIMARY | Rare Disease Therapeutics, Inc. Dba Rare Disease Therapeutics Inc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM217242 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1597692 | 5/1 Secondary reference U.S. Government activity |
| ANAVIP | 5/1 Secondary reference Rare Disease Therapeutics, Inc. Dba Rare Disease Therapeutics Inc |
NSN 6505-01-696-3047 is a Antivenin,crotalidae,polyvalent, manufactured by Rare Disease Therapeutics, Inc. Dba Rare Disease Therapeutics Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-696-3047 has 1 manufacturer part number on file: NDC66621-0790-02 (Rare Disease Therapeutics, Inc. Dba Rare Disease Therapeutics Inc).
Key specifications for NDC66621-0790-02: Special Features: EACH CARTON NDC 66621-0790-2 CONTAINS 1 VIAL OF ANAVIP NDC 66621-0790-1. INDICATED FOR THE MANAGEMENT OF ADULT AND PEDIATRIC PATIENTS WITH NORTH AMERICAN PIT VIPER ENVENOMATION; SUPPLIED AS A STERILE, LYOPHILIZED POWDER; PREPARATION IN A SINGLE-DOSE VIAL; WHEN RECONSTITUTED WITH 10 ML OF 0.9% NACL SOLUTION, EACH VIAL CONTAINS NOT MORE THAN 12 MG PER ML OF PROTEIN; STORE AT ROOM TEMPERATURE (UP TO 25 C (77 F)); BRIEF TEMPERATURE EXCURSIONS ARE PERMITTED UP TO 40 C (104 F). DO NOT FREEZE; USE WITHIN 6 HOURS AFTER RECONSTITUTION; DISCARD PARTIALLY USED VIALS; SINGLE DOSE VIAL; FOR INTRAVENOUS USE ONLY; SHELF LIFE: 3 YEARS.; Part Name Assigned by Controlling Agency: CROTALIDAE SOLUTION INJECTIONS, POWDER, LYOPHILIZED, VIAL. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.